Pacific Biosciences of California (MEX:PACB) Market Cap: MXN9,414 Mil (As of Jun. 30, 2026)


MEX:PACB Pacific Biosciences of California Inc MEX:PACB
53 GF Score
Price MXN27.50
GF Value MXN25.68
! 7 Warning Signs
View Full Analysis

What is Pacific Biosciences of California Market Cap?

Pacific Biosciences of California MEX:PACB 53 Market Cap is MXN9,414 Mil as of Jun. 30, 2026. GuruFocus rates MEX:PACB with a GF Score™ of 53/100 and a GF Value™ of MXN25.68. The stock has 7 warning signs investors should review. Among 867 Medical Devices & Instruments companies, Pacific Biosciences of California ranks better than 70.82% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Pacific Biosciences of California's share price for the quarter that ended in Mar. 2026 was MXN27.5. Pacific Biosciences of California's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 310 Mil. Therefore, Pacific Biosciences of California's market cap for the quarter that ended in Mar. 2026 was MXN8,538 Mil.

Pacific Biosciences of California's quarterly market cap increased from Sep. 2025 (MXN6,707 Mil) to Dec. 2025 (MXN8,452 Mil) and increased from Dec. 2025 (MXN8,452 Mil) to Mar. 2026 (MXN8,538 Mil).

Pacific Biosciences of California's annual market cap stayed the same from Dec. 2023 (MXN0 Mil) to Dec. 2024 (MXN0 Mil) but then increased from Dec. 2024 (MXN0 Mil) to Dec. 2025 (MXN8,452 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Pacific Biosciences of California's Enterprise Value for Today is MXN16,902 Mil.


Pacific Biosciences of California  (MEX:PACB) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Pacific Biosciences of California Market Cap Related Terms


Pacific Biosciences of California Market Cap Historical Data

* Premium members only.

The historical data trend for Pacific Biosciences of California's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pacific Biosciences of California Market Cap Chart

Pacific Biosciences of California Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 8,451.75

Pacific Biosciences of California Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 6,673.78 6,707.17 8,451.75 8,538.39

MEX:PACB vs KIDS, MOBI, SI: Market Cap Comparison

For the Medical Devices subindustry, Pacific Biosciences of California's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pacific Biosciences of California Market Cap vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pacific Biosciences of California's Market Cap distribution charts can be found below:

* The bar in red indicates where Pacific Biosciences of California's Market Cap falls into.


MEX:PACB
53GF Score
Pacific Biosciences of California Inc MEX:PACB
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pacific Biosciences of California Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Pacific Biosciences of California's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as

Market Cap (A: Dec. 2025 )=Share Price (A: Dec. 2025 )*Shares Outstanding (EOP) (A: Dec. 2025 )
=MXN27.99*301.956
=MXN8,452

Pacific Biosciences of California's Market Cap for the quarter that ended in Mar. 2026 is calculated as

Market Cap (Q: Mar. 2026 )=Share Price (Q: Mar. 2026 )*Shares Outstanding (EOP) (Q: Mar. 2026 )
=MXN27.5*310.487
=MXN8,538

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of MXN9,414 Mil mean?
Pacific Biosciences of California (MEX:PACB) has a Market Cap of MXN9,414 Mil as of Jun. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Pacific Biosciences of California and its competitors. According to the industry distribution chart, Pacific Biosciences of California ranks #253 out of 867 companies in the Medical Devices & Instruments industry, placing it in the top 29.2%.
Is Pacific Biosciences of California's Market Cap too high?
Pacific Biosciences of California's current Market Cap is MXN9,414 Mil. Based on the distribution chart, Pacific Biosciences of California ranks #253 out of 867 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Pacific Biosciences of California has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does Pacific Biosciences of California's Market Cap compare to KIDS and MOBI?
According to the Medical Devices & Instruments industry distribution chart, Pacific Biosciences of California ranks #253 out of 867 companies for Market Cap. This puts Pacific Biosciences of California in the upper half of its industry. The industry median Market Cap is 120.18. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 120.18, based on 867 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Pacific Biosciences of California and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 120.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pacific Biosciences of California's current Market Cap is MXN9,414 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pacific Biosciences of California stock overvalued right now?
Pacific Biosciences of California (MEX:PACB) has a current Market Cap of MXN9,414 Mil. The stock's GF Value™ is MXN25.68, compared to a current price of MXN27.50 — trading 7.1% above its estimated fair value. The current Market Cap is MXN9,414 Mil. Pacific Biosciences of California's overall GF Score™ is 53/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Pacific Biosciences of California (MEX:PACB), the current Market Cap is MXN9,414 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pacific Biosciences of California (MEX:PACB) Overvalued in 2026?

Based on GuruFocus' analysis, Pacific Biosciences of California stock appears to be overvalued. The current stock price of MXN27.50 is trading 7.1% above its estimated GF Value™ of MXN25.68.

Key valuation signals for MEX:PACB:

  • Market Cap: MXN9,414 Mil
  • GF Value™: MXN25.68 vs. price of MXN27.50 (7.1% above fair value)
  • GF Score™: 53/100 with 7 warning signs

No single metric tells the full story. See the MEX:PACB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pacific Biosciences of California Business Description

Other Exchanges PACB:USAP09:Germany
Address 1305 O’Brien Drive, Menlo Park, CA, USA, 94025
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
53GF Score

Get the complete analysis for MEX:PACB

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN27.50
Price
MXN25.68
GF Value